By Clare Saliba E-Commerce Times
02/13/01 10:43 AM PT
PlanetRX is putting a positive spin on its closure and
says it plans to 'refocus' on the specialty prescription business.
Better Email Security Just Got A Whole Lot Easier. And Cheaper. Introducing Security Software As A Service From Webroot. Free 14-Day Trial.
After struggling to secure an infusion of capital, ailing online pharmacy PlanetRX.com announced Monday that it
had stopped accepting new prescriptions, effective immediately, and will
discontinue the sale of health and beauty products from its Web site on
March 12th.
The company will refer its former customers to rival Drugstore.com.
PlanetRX.com has already taken steps to sell the company's distribution
center and other assets, and said it intends to shift its focus to
fulfilling specialty prescriptions.
According to PlanetRX.com chairman and chief executive officer
Michael Beindorff, the shift towards the specialty pharmacy market is
"an effort that we have been working on for quite some time."
The company has high hopes for its future in the specialty pharmacy
business, which it said accounts
for US$14 billion in annual sales in the U.S. and
has a greater growth rate than the overall pharmacy market.
Good Intentions
San Francisco, California-based PlanetRX.com also said it had signed a binding letter of
intent to acquire a yet-to-be-named existing specialty pharmacy business. Planet RX.com
anticipates finalizing the agreement by February 21st, the date it issues its
fourth-quarter and year-end earnings report.
Beindorff said that the agreement would allow PlanetRX.com to apply its
health care expertise and other assets to "a faster-growing,
less costly, higher-margin business opportunity."
The agreement is contingent upon approval by its board of directors.
If approved, the company will operate the new
specialty prescription business through its current namesake Web site.
Drugstore.com's Gain
In a bid to lure PlanetRX.com's existing customer
base, Drugstore.com will start notifying the company's
1.4 million members this week about the impending
closure through announcements on its site and e-mail messages.
To ease the transition, PlanetRX.com said the deal it brokered with
Drugstore.com would allow for the electronic transfer of all prescription
drug accounts to its former competitor, although participation in the
referral program will be voluntary and information will be shared only at
the request of customers.
"Through this arrangement, PlanetRX customers will continue to receive low
Internet prices on their prescriptions, as well as enjoy easy access to a
convenient online store," Drugstore.com chairman and chief
executive officer Peter Neupert said.
Not Pretty
Like many other e-commerce sectors, the online health and beauty industry
has struggled in recent months. This past fall, market research firm
InsightExpress issued a report calling online
pharmacies a "prescription for failure," saying that
93 percent of online shoppers
had never made a purchase from an online drugstore and
76 percent had never even visited one.
PlanetRX.com saw its fortunes wane with the market slide. In January, the company
was delisted from the
Nasdaq after failing to climb above the $1 mark in trading.
Looking at Drugstore.com
By comparison, Drugstore.com has not reached the
breaking point that other Web merchants have.
Despite staff layoffs
and an executive departure last month, the Bellevue, Washington-based company
reported a narrower-than-expected loss for the fourth quarter and said that
net sales for the period topped sales figures for all of 1999.
Drugstore.com also said that during the fourth quarter, it added 257,000 customers
to its roster -- a number that will spike
again with the transfer of PlanetRX accounts. Drugstore.com has an alliance
with Internet giant Amazon.com.
Drugstore.com said that it can reach an operating cash
flow of breakeven in 2004 with the cash it currently
has on hand, which was approximately $130 million as of the
end of the fourth quarter, according to
the company.
Investors in the company appeared pleased with the news that Drugstore.com was
gaining a new customer base. On Tuesday morning, the stock gained
19 cents to reach $1.50, well off its 52-week high of $31, but
more double its 52-week low.